4.90
price up icon0.62%   0.03
after-market Dopo l'orario di chiusura: 4.92 0.02 +0.41%
loading

Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Costs And Expenses
5.77%
25.45
24.06 33.18 21.16 24.16
Operating Income/Loss
5.77%
-25.45
-24.06 -33.18 -21.16 -24.16
Nonoperating Income/Loss
2.66%
3.17
3.088 3.475 3.335 2.689
Income/Loss From Continuing Operations Before Tax
6.23%
-22.28
-20.97 -29.71 -17.82 -21.47
Income Tax Expense/Benefit
97.96%
0.097
0.049 0.058 0.072 0.06
Income/Loss From Continuing Operations After Tax
6.44%
-22.37
-21.02 -29.77 -17.90 -21.53
Net Income/Loss
6.44%
-22.37
-21.02 -29.77 -17.90 -21.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
20,457%
74.40
0.3619 71.53 71.36 69.78
Diluted Average Shares
20,457%
74.40
0.3619 71.53 71.36 69.78
Basic Earnings Per Share
3.45%
-0.30
-0.29 -0.42 -0.25 -0.31
Diluted Earnings Per Share
3.45%
-0.30
-0.29 -0.42 -0.25 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.40
price down icon 2.10%
$35.84
price down icon 0.78%
$25.00
price down icon 3.40%
$98.18
price up icon 1.57%
$112.89
price down icon 0.90%
biotechnology ONC
$250.30
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):